Qingyu Lin

机构：Sun Yat-sen University, Hefei University of Technology, Fudan University, Wuhan University, Institute of Nuclear Physics, Catalytic Materials (United States), Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University, Shanghai Institute of Hematology, Ministry of Industry and Information Technology · ORCID：0000-0001-9463-9363

发表论文 64 篇 · 总被引 1938 次 · h-index 20

代表论文

• SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation (2023 · Molecular Cell · 被引 110)
• The opportunities and challenges in immunotherapy: Insights from the regulation of PD-L1 in cancer cells (2023 · Cancer Letters · 被引 78)
• lncRNA HITT Inhibits Lactate Production by Repressing PKM2 Oligomerization to Reduce Tumor Growth and Macrophage Polarization (2022 · Research · 被引 41)
• Long noncoding RNA HITT coordinates with RGS2 to inhibit PD-L1 translation in T cell immunity (2023 · Journal of Clinical Investigation · 被引 33)
• Fluorine-18: Radiochemistry and Target-Specific PET Molecular Probes Design (2022 · Frontiers in Chemistry · 被引 33)
• 124 I-Labeled Monoclonal Antibody and Fragment for the Noninvasive Evaluation of Tumor PD-L1 Expression In Vivo (2022 · Molecular Pharmaceutics · 被引 21)